Empirical caspofungin therapy in clinical practice for suspected invasive fungal disease in adults with acute lymphoblastic leukaemia.

about

Empirical caspofungin therapy in clinical practice for suspected invasive fungal disease in adults with acute lymphoblastic leukaemia.

Item

http://www.wikidata.org/entity/Q41580172

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Empirical caspofungin therapy ...... acute lymphoblastic leukaemia.

@en

type

Item

label

Empirical caspofungin therapy ...... acute lymphoblastic leukaemia.

@en

prefLabel

Empirical caspofungin therapy ...... acute lymphoblastic leukaemia.

@en

P1476

Empirical caspofungin therapy ...... acute lymphoblastic leukaemia.

@en

P2093

Barbara Gross

http://www.w3.org/2001/XMLSchema#string

Gerlinde Egerer

http://www.w3.org/2001/XMLSchema#string

Michael G Kiehl

http://www.w3.org/2001/XMLSchema#string

Monika Engelhardt

http://www.w3.org/2001/XMLSchema#string

P2860

Acute lymphoblastic leukaemia

Projection of Morbidity 2030 and 2050: Impact for the National Health System and Blood Supply.

Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients.

Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441 patients

Phase II dose escalation study of caspofungin for invasive Aspergillosis.

Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.

Nosocomial fungal infections: epidemiology, diagnosis, and treatment.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

Antifungal treatment strategies in high risk patients.

Treatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

P304

76-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/MYC.12277

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25590660

http://www.w3.org/2001/XMLSchema#string

P921

leukemia